Trending

Innoviva

Under-pressure GSK sells stake in respiratory diseases partner Innoviva

Under-pressure GSK sells stake in respiratory diseases partner Innoviva

GlaxoSmithKline has sold its entire stake in its respiratory partner Innoviva, raising $392 million and simplifying its business

X

Under-pressure GSK sells stake in respiratory diseases partner Innoviva

https://pharmaphorum.com/news/gsk-sells-stake-in-respiratory-diseases-partner-innoviva/

GSK aims to get triple therapy approved for asthma in US

GSK aims to get triple therapy approved for asthma in US

GlaxoSmithKline and development partner Innoviva have filed a dossier with the FDA, in a bid to get their

X

GSK aims to get triple therapy approved for asthma in US

https://pharmaphorum.com/news/gsk-bids-to-become-first-asthma-triple-therapy-on-the-us-market/

GSK to file COPD combo a year earlier in US

GSK to file COPD combo a year earlier in US

Filing for triple therapy later this year.

X

GSK to file COPD combo a year earlier in US

https://pharmaphorum.com/news/gsk-brings-forward-filing-of-copd-drug/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com